News stories about UnitedHealth Group (NYSE:UNH) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. UnitedHealth Group earned a coverage optimism score of 0.22 on Accern’s scale. Accern also gave news headlines about the healthcare conglomerate an impact score of 46.5970649797359 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:
- United Health Foundation, Cankdeska Cikana Community College Launch New $1.2 Million Partnership to Expand Access to Substance Abuse Treatment for the Spirit Lake Dakota Community (finance.yahoo.com)
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% (investing.com)
- UnitedHealth Group Board Authorizes Payment of Quarterly Dividend to Shareholders (finance.yahoo.com)
- William McNabb Joins UnitedHealth Group Board of Directors (markets.financialcontent.com)
- UnitedHealth Group Inc (UNH) to Issue Quarterly Dividend of $0.75 (americanbankingnews.com)
UNH has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a research note on Saturday, January 20th. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price objective on the stock. Credit Suisse Group boosted their price target on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a research note on Monday, December 25th. Finally, Piper Jaffray Companies boosted their price target on shares of UnitedHealth Group to $242.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 29th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $243.22.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.11 earnings per share. analysts predict that UnitedHealth Group will post 12.51 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.
In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now directly owns 76,637 shares in the company, valued at approximately $18,881,824.06. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,396 shares of company stock worth $12,262,067. 0.89% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact UnitedHealth Group (UNH) Share Price” was reported by BBNS and is the sole property of of BBNS. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://baseballnewssource.com/markets/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-unitedhealth-group-unh-share-price/1887050.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.